90 likes | 321 Views
About Infectious Disease Treatment Infectious diseases can be caused by various pathogenic microorganisms such as bacteria, fungi, parasites, or viruses. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on the target organism, anti-infective drugs can be categorized into antibacterial, antiviral, antifungal, and antiparasitic. Anti-infective drugs can act via host defence system or can directly target the causative agent. Get full access of the report at: http://www.researchbeam.com/global-infectious-disease-treatment-2014-2018-market
E N D
Global Infectious Disease Treatment Market 2014-2018 Publish By: Technovia Toll Free: +1 (855) 711-1555 Email: sales@researchbeam.com
Report Overview About Infectious Disease Treatment Infectious diseases can be caused by various pathogenic microorganisms such as bacteria, fungi, parasites, or viruses. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on the target organism, anti-infective drugs can be categorized into antibacterial, antiviral, antifungal, and antiparasitic. Anti-infective drugs can act via host defence system or can directly target the causative agent. TechNavio'sanalysts forecast the Global Infectious Disease Treatment market to grow at a CAGR of 3.43 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Global Infectious Disease Treatment market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of various drugs administered to treat various infectious diseases caused by bacteria, virus, fungi, and parasites, which include: • Antibacterial drugs (beta-lactams, macrolides, aminoglycosides, phenicols, quinolones, sulfonamides, tetracyclines, and other antibacterials)
Report Overview • Antiviral drugs (HIV, hepatitis C, hepatitis B, and other antivirals) • Antifungal drugs (azoles, pyrimidines, echinodians, polyenes, allylamines, and other antifungal drugs) • Antiparasiticdrugs TechNavio'sreport, the Global Infectious Disease Treatment Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Infectious Disease Treatment market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Get full access of the report at: http://www.researchbeam.com/global-infectious-disease-treatment-2014-2018-market Key Regions • Americas • APAC • EMEA
Report Overview Key Vendors • F. Hoffmann-La Roche • Gilead Sciences • GlaxoSmithKline • Johnson & Johnson • Merck • Pfizer Other Prominent Vendors • Achillion Pharmaceuticals • AbbVie • AstellasPharma • AstraZeneca • Auritec Pharmaceuticals • Bayer • Bristol-Myers Squibb • Chimerix Pharmaceuticals • Cubist
Table Of Content 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Market Landscape 06.1 Market Overview
Table Of Content 06.2 Market Size and Forecast 06.3 Five Forces Analysis 07. Market Segmentation by Application 08. Global Antibacterial Drugs Market 08.1 Introduction 08.2 Market Size and Forecast 08.3 Market Segmentation by Chemical Class 08.4 Market Segmentation by Drug Origin 09. Global Antifungal Drugs Market 09.1 Introduction
List of Exhibits Exhibit 1: Market Research Methodology Exhibit 2: Global Infectious Disease Treatment Market 2013-2018 (US$ million) Exhibit 3: Global Infectious Disease Treatment Market Segmentation by Application Exhibit 4: Global Infectious Disease Treatment Market Segmentation by Application 2013 Exhibit 5: Global Infectious Disease Treatment Market Segmentation by Application 2018 Exhibit 6: Global Infectious Disease Treatment Market Segmentation by Application 2013-2018 (US$ million) Exhibit 7: Global Infectious Disease Treatment Market Segmentation by Application 2013-2018 Exhibit 8: Snapshot of Global Infectious Disease Treatment Market Segments 2013-2018 Exhibit 9: YoY Growth Rate of Global Infectious Disease Treatment Market Segments 2013-2018 Exhibit 10: Global Antibacterial Drugs Market: Key Drivers and Challenges
List of Exhibits Exhibit 11: Global Antibacterial Drugs Market 2013-2018 (US$ million) Exhibit 12: Global Antibacterial Drugs Market Segmentation by Chemical Class Exhibit 13: Cephalosporin Segmentation by Generation of Drugs Exhibit 14: Global Antibacterial Drugs Market Revenue Segmentation by Chemical Class 2013 Exhibit 15: Global Antibacterial Drugs Market Segmentation by Chemical Class in Volume 2013 Exhibit 16: Global Antibacterial Drugs Market Segmentation by Drug Origin Exhibit 17: Global Antifungal Drugs Market: Key Drivers and Challenges Exhibit 18: Global Antifungal Drugs Market 2013-2018 (US$ million) To make an enquiry before purchasing the report, visit at: http://www.researchbeam.com/global-infectious-disease-treatment-2014-2018-market/purchase-enquiry
Contact Us Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 Fax: +1 (855) 550-5975 Web: www.researchbeam.com Email: sales@researchbeam.com Deep 5320 SW Macadam Avenue, Suite 100, Portland, OR 97239 United States